{"id":26261,"date":"2024-06-20T04:20:00","date_gmt":"2024-06-19T20:20:00","guid":{"rendered":"http:\/\/csccm.org.cn\/?p=26261"},"modified":"2024-06-20T04:30:26","modified_gmt":"2024-06-19T20:30:26","slug":"jama%e5%8f%91%e8%a1%a8%e8%ae%ba%e6%96%87%ef%bc%9a%e5%bb%b6%e9%95%bf%e6%88%96%e9%97%b4%e6%96%ad%e8%be%93%e6%b3%a8%ce%b2-%e5%86%85%e9%85%b0%e8%83%ba%e7%b1%bb%e6%8a%97%e7%94%9f%e7%b4%a0%e6%b2%bb","status":"publish","type":"post","link":"https:\/\/csccm.org.cn\/?p=26261","title":{"rendered":"[JAMA\u53d1\u8868\u8bba\u6587]\uff1a\u5ef6\u957f\u6216\u95f4\u65ad\u8f93\u6ce8\u03b2-\u5185\u9170\u80fa\u7c7b\u6297\u751f\u7d20\u6cbb\u7597\u6210\u5e74\u8113\u6bd2\u75c7\u6216\u611f\u67d3\u6027\u4f11\u514b\u60a3\u8005"},"content":{"rendered":"\n<p>Original Investigation&nbsp;<\/p>\n\n\n\n<p>Caring for the Critically Ill Patient<\/p>\n\n\n\n<p>June&nbsp;12,&nbsp;2024<\/p>\n\n\n\n<h1 class=\"wp-block-heading\">Prolonged vs Intermittent Infusions of \u03b2-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis<\/h1>\n\n\n\n<h3 class=\"wp-block-heading\">Mohd H.\u00a0Abdul-Aziz,\u00a0Naomi E.\u00a0Hammond,\u00a0Stephen J.\u00a0Brett,\u00a0et al<\/h3>\n\n\n\n<h3 class=\"wp-block-heading\"><em>JAMA.\u00a0<\/em>Published online June 12, 2024. doi:10.1001\/jama.2024.9803<\/h3>\n\n\n\n<p>Key Points<\/p>\n\n\n\n<p><strong>Question<\/strong>&nbsp;&nbsp;Does the administration of \u03b2-lactam antibiotics by prolonged infusion reduce 90-day mortality compared with intermittent infusion in adult patients with sepsis or septic shock?<\/p>\n\n\n\n<p><strong>Findings<\/strong>&nbsp;&nbsp;This systematic review and bayesian meta-analysis of 18 randomized trials that included 9108 critically ill adults with sepsis or septic shock reported a 99.1% posterior probability that prolonged infusions were associated with lower 90-day mortality compared with intermittent infusions (risk ratio, 0.86).<\/p>\n\n\n\n<p><strong>Meaning<\/strong>&nbsp;&nbsp;Prolonged infusions of \u03b2-lactam antibiotics are associated with a reduced risk of death in critically ill adult patients with sepsis or septic shock compared with intermittent infusions.<a><\/a><\/p>\n\n\n\n<p>Abstract<\/p>\n\n\n\n<p><strong>Importance<\/strong>&nbsp;&nbsp;There is uncertainty about whether prolonged infusions of \u03b2-lactam antibiotics improve clinically important outcomes in critically ill adults with sepsis or septic shock.<\/p>\n\n\n\n<p><strong>Objective<\/strong>&nbsp;&nbsp;To determine whether prolonged \u03b2-lactam antibiotic infusions are associated with a reduced risk of death in critically ill adults with sepsis or septic shock compared with intermittent infusions.<\/p>\n\n\n\n<p><strong>Data Sources<\/strong>&nbsp;&nbsp;The primary search was conducted with MEDLINE (via PubMed), CINAHL, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), and ClinicalTrials.gov from inception to May 2, 2024.<\/p>\n\n\n\n<p><strong>Study Selection<\/strong>&nbsp;&nbsp;Randomized clinical trials comparing prolonged (continuous or extended) and intermittent infusions of \u03b2-lactam antibiotics in critically ill adults with sepsis or septic shock.<\/p>\n\n\n\n<p><strong>Data Extraction and Synthesis<\/strong>&nbsp;&nbsp;Data extraction and risk of bias were assessed independently by 2 reviewers. Certainty of evidence was evaluated with the Grading of Recommendations Assessment, Development and Evaluation approach. A bayesian framework was used as the primary analysis approach and a frequentist framework as the secondary approach.<\/p>\n\n\n\n<p><strong>Main Outcomes and Measures<\/strong>&nbsp;&nbsp;The primary outcome was all-cause 90-day mortality. Secondary outcomes included intensive care unit (ICU) mortality and clinical cure.<\/p>\n\n\n\n<p><strong>Results<\/strong>\u00a0\u00a0From 18 eligible randomized clinical trials that included 9108 critically ill adults with sepsis or septic shock (median age, 54 years; IQR, 48-57; 5961 men [65%]), 17 trials (9014 participants) contributed data to the primary outcome. The pooled estimated risk ratio for all-cause 90-day mortality for prolonged infusions of \u03b2-lactam antibiotics compared with intermittent infusions was 0.86 (95% credible interval, 0.72-0.98;\u00a0<em>I<\/em><sup>2<\/sup>\u2009=\u200921.5%; high certainty), with a 99.1% posterior probability that prolonged infusions were associated with lower 90-day mortality. Prolonged infusion of \u03b2-lactam antibiotics was associated with a reduced risk of intensive care unit mortality (risk ratio, 0.84; 95% credible interval, 0.70-0.97; high certainty) and an increase in clinical cure (risk ratio, 1.16; 95% credible interval, 1.07-1.31; moderate certainty).<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jama\/0\/joi240071f1_1717683096.88587.png?Expires=1721237837&amp;Signature=q0CY9KVFjsQg5z856TzhWroB0PbBnaW1XxeN~0rODYodCeqcDVxEkHgElAzTJSXWrNP68OpSyaT1Pxzux5Vq27lnqhRio59CUlF0SYv26yPzcqML~LkJlTtpe4yvbDw~tkascCO5CAfMXZdEVj19P3qFl3khfxAFK1ZMnffmykhwTOtu-C77EVNkqaP42f-zVqV3YxGtoxPry8MQqBl4R6bTP3txtPn4oNXjYeKMqB85KAzGIXto~DgEd7VOfIVJURd0IfzlaAxJjs6Ym2q4JRTEilTdJSKr90jiJUkxfZdtt79FMxJo5qP5Ezl416oGxH3rIUxNXawwhFCm91069A__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jama\/0\/joi240071f2_1717683096.89587.png?Expires=1721237837&amp;Signature=I9OzwWIpiewuEOpBBxY8Fc3116bLwC~pubr~Tt31f8jZ6FPJLSA54IMw~czKP3OfJpRKEZ~pF0tod6m-Muv2rjS2DR4y760sAaZ5mMO71uMJbLe4sVLHN3nIhkMd8Q73dBo5bCRj5732pHhoJtgPsIpgIiVUPOjLDZRar6f3Kabl76sGd4K0NP2mREwZENsGEE5yEs~LLdYDEwX44SHwoGqeaw1Rrq-cZzrDqCfKYxUSnzD9jp-XnQKuzg2AtXgK27aE-pZkmNA1gDtQiYoWw68gzeXqDvFuPg7kX5LfoNXCKU9piQxj18-1aIuCJ2g4qLX0QlKkWh-F90JyY1NU7w__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jama\/0\/joi240071f3_1717683096.90086.png?Expires=1721237837&amp;Signature=ZlZ-0w6I8PhTLZgFOdBCNUsMNUhGv~FyrRMJsKi5LhCWyHbK12rROZxujj2L3pZ4xGZtqRTMLLL0SBv9vUaulZdaFlLOgd~DTdaOWtsKdQWt9QEnPegvyIuRgyVoTu6VDZSR5DqJnmvOhWe-2cmE69jn9Em7aNDBRk99ocHHatHK2ubCg7fd-g8BHwY~4dYuervzcPzOxl4qRDpnAVDNaq-2GkoSlzLNCJinfNnfvgaehpSPm-~f9cD0fmavJe~YYdJfSXuybQZluwDYRn6cjOYvTrRcUnVZCstxWnI~hPwo5kmfLyJUbfuKzBBEN9tGPHg3jbG15j9ZfcowA43hSg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jama\/0\/joi240071t1_1717683096.85586.png?Expires=1721237837&amp;Signature=WGCS-tTFoj1SIafuybOPJmP9wK2nxg6s8BHR-An1Q2S6mZ1LacCT78HlhTSbyDCrYJhbLo4HbVkLTeVA7hanlD4ZY7RG-Of6On1OYXWUBUH7MCedwIt-NmFo32xxIMvUcLTXkG-I7RKRjh8aZWYdXn3BfF2efTj~fN1628ZTMjSdzI4TceREvci~rULhZ36uT1PmMVWZVAGyJl73~LntY7OW793iBKSlKkl-qSVEEt97MBAnHuEQfQ3zZoA3~NtE5J0~VYzWR8bUuPQ~eJH9B2Ri0q4AqPNUSKxdUVbPmwRpCBv65EU4bTpcphMfWbMhfn4ECT2WV6hHXDN61k3KRA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jama\/0\/joi240071t2_1717683096.91086.png?Expires=1721237837&amp;Signature=ZgJqGM4r2uhnNbLa7W9YtQfs1DeRciZtcEYUORXQgQyhPJsQ7FwvqWGrtj89Aorho2l-EgsmMUadgPWkWDziGPSJnHiDIEMprOsj5EH3fAJTmKAJaHJLnhGbDpjGUCeloBLIOw2Aau-F0IU-tvS32HUmQk7H-w~7V~QyQ4rFTmsxqAPWBN6FPt1znkw1IKkckm5D8LEbShFZ3C5lozN8Jqx6ttNgI32jHF9btVnZfjJVsPtiXbpFWuGD9TpTEKuJtB42wm24dIbyZUlopioO28n0cBlf8Xd90T0gkNfE3~IqFgjlMFp4ptsaAR-BQnprwWcC8KrA1Upqdz7dIS1i3w__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<p><strong>Conclusions and Relevance<\/strong>&nbsp;&nbsp;Among adults in the intensive care unit who had sepsis or septic shock, the use of prolonged \u03b2-lactam antibiotic infusions was associated with a reduced risk of 90-day mortality compared with intermittent infusions. The current evidence presents a high degree of certainty for clinicians to consider prolonged infusions as a standard of care in the management of sepsis and septic shock.<\/p>\n\n\n\n<p><strong>Trial Registration<\/strong>&nbsp;&nbsp;PROSPERO Identifier:&nbsp;<a href=\"https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=399434\">CRD42023399434<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Original Investigation&nbsp; Caring for the Critically  [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[32,23],"tags":[],"_links":{"self":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts\/26261"}],"collection":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=26261"}],"version-history":[{"count":1,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts\/26261\/revisions"}],"predecessor-version":[{"id":26262,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts\/26261\/revisions\/26262"}],"wp:attachment":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=26261"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=26261"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=26261"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}